retisert implant
bausch & lomb inc - fluocinolone acetonide - implant - 0.59mg - fluocinolone acetonide 0.59mg - corticosteroids
synalar ointment
bausch health, canada inc. - fluocinolone acetonide - ointment - 0.025% - fluocinolone acetonide 0.025% - anti-inflammatory agents
synalar solution
bausch health, canada inc. - fluocinolone acetonide - solution - 0.01% - fluocinolone acetonide 0.01% - anti-inflammatory agents
dermotic oil ear drops solution
hill dermaceuticals inc - fluocinolone acetonide - solution - 0.01% - fluocinolone acetonide 0.01% - corticosteroids
iluvien implant
knight therapeutics inc. - fluocinolone acetonide - implant - 0.19mg - fluocinolone acetonide 0.19mg - corticosteroids
derma smoothe/fs liq 0.01% emulsion
hill dermaceuticals inc - fluocinolone acetonide - emulsion - 0.01% - fluocinolone acetonide 0.01% - anti-inflammatory agents
cetraxal
cts ltd - ciprofloxacin as hydrochloride; fluocinolone acetonide - ear drops - ciprofloxacin as hydrochloride 3 mg / 1 ml; fluocinolone acetonide 0.25 mg / 1 ml - ciprofloxacin - ciprofloxacin - cetraxal is indicated in adults and in children aged 6 months and older for the following infections:- acute otitis externa (aoe)- acute otitis media in patients with tympanostomy tubes (aomt)caused by ciprofloxacin susceptible microorganisms.consideration should be given to official guidance on the appropriate use of antibacterial agents.
coal tar solution 3.3% / propylene glycol 20% in fluocinolone acetonide 0.025% gel
special order - coal tar solution; propylene glycol; fluocinolone acetonide - cutaneous gel - 33mg/1gram ; 200mg/1gram ; 191.75microgram/1gram
neo-synalar- neomycin sulfate and fluocinolone acetonide kit
medimetriks pharmaceuticals - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), fluocinolone acetonide (unii: 0cd5fd6s2m) (fluocinolone acetonide - unii:0cd5fd6s2m) - neo-synalar® cream is indicated for the treatment of corticosteroid-responsive dermatoses with secondary infection. it has not been demonstrated that this steroid-antibiotic combination provides greater benefit than the steroid component alone after 7 days of treatment (see warnings section) . topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation. this product should not be used in the external auditory canal if the eardrum is perforated.
neo-synalar- neomycin sulfate and fluocinolone acetonide cream
medimetriks pharmaceuticals - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), fluocinolone acetonide (unii: 0cd5fd6s2m) (fluocinolone acetonide - unii:0cd5fd6s2m) - neo-synalar® cream is indicated for the treatment of corticosteroid-responsive dermatoses with secondary infection. it has not been demonstrated that this steroid-antibiotic combination provides greater benefit than the steroid component alone after 7 days of treatment (see warnings section) . topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation. this product should not be used in the external auditory canal if the eardrum is perforated.